Cingulate begins Phase 3 tests of novel treatment for ADHD
January 09, 2023 at 08:25 AM EST
Cingulate's technology will let patients receive treatment ADHD treatment without second doses, boosters to get through the day.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|